Frontage Holdings Corp is Frontage Holdings Corp (Frontage), a subsidiary of Hong Kong Tigermed Co Ltd, is a biotechnology company that provides contract research organization. The company focused on drug candidate evaluation solutions, product development and CMC solutions, clinical services solutions and central laboratories and testing. Its drug candidate evaluation services comprise organic chemistry services, safety and toxicology, bioanalytical and genomics. Frontage clinical services include clinical study experience, BE/BA studies, biometrics and data management. The company also provides central laboratories and testing and COVID-19 capabilities and testing services. It serves pharma, medical and life science companies. The company has operations in the US and China. Frontage is headquartered in Exton, Pennsylvania, the US.
Frontage Holdings Corp premium industry data and analytics
Products and Services
Services |
---|
Drug Candidate Evaluation Solutions: |
Organic Chemistry Services |
Bioanalytical |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Frontage Holdings Corp | SciClone Pharmaceuticals Holdings Ltd | HitGen Inc | CARsgen Therapeutics Ltd | Labcorp Drug Development |
---|---|---|---|---|---|
Headquarters | United States of America | China | China | China | United States of America |
City | Exton | Shanghai | Chengdu | Shanghai | Burlington |
State/Province | Pennsylvania | Shanghai | Sichuan | Shanghai | North Carolina |
No. of Employees | 1,613 | 1,000 | 508 | 525 | 26,000 |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Song Li | Chairman | Executive Board | 2021 | 65 |
Zhihe Li | Director | Executive Board | 2018 | 68 |
Abdul Ezaz Mutlib | Chief Executive Officer | Senior Management | 2023 | 62 |
Henry Gao | President - Asia Pacific; Chief Financial Officer | Senior Management | 2024 | - |
Dongmei Wang | Executive Vice President | Senior Management | 2017 | 59 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward